Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

301.02 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 36
Open 301.02
Bid (Size) 286.50 (1)
Ask (Size) 324.00 (4)
Prev. Close 301.02
Today's Range 301.02 - 301.02
52wk Range 225.28 - 325.19
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy? 
Via Talk Markets
3 No-Brainer Growth Stocks to Buy in 2023
These stocks all fell by double digits last year. 
Via The Motley Fool

Performance

YTD
+5.24%
+5.24%
1 Month
+3.74%
+3.74%
3 Month
-0.73%
-0.73%
6 Month
+2.41%
+2.41%
1 Year
+23.74%
+23.74%

More News

Read More
Why Editas Medicine's Shares Jumped This Week
Via The Motley Fool
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
Via The Motley Fool
BioRestorative (NASDAQ: BRTX) Ramps Up Production In Anticipation Of Positive Phase 2 Results
Via Benzinga
3 No-Brainer Stocks to Buy in February
Via The Motley Fool
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,600 Today
Via Benzinga
The Best Stocks to Invest $20,000 in Right Now
Via The Motley Fool
Is Editas Medicine Stock a Buy Now?
Via The Motley Fool
2 Surefire Stocks to Buy in 2023 and Hold for at Least the Next Decade
Via The Motley Fool
The 10 Best Stocks to Buy in February 2023
Via The Motley Fool
A New Bull Market Could Arrive in February: 3 Stocks to Buy Now
Via The Motley Fool
3 Things About CRISPR Therapeutics That Smart Investors Know
Via The Motley Fool
The Latest Analyst Ratings for Vertex Pharmaceuticals
Via Benzinga
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
Via The Motley Fool
3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later
Via InvestorPlace
7 Cream-of-the-Crop Stocks to Buy Today
Via InvestorPlace
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season
Via Talk Markets
Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?
Via The Motley Fool
BP Stock, Baidu Lead 5 Stocks Near Buy Points With Big Growth Potential
Via Investor's Business Daily
3 Smart Stocks to Buy if a Recession Is on the Way
Via The Motley Fool
The Best Stocks to Invest $5,000 In Right Now
Via The Motley Fool
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Via The Motley Fool
Incyte Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
Via Investor's Business Daily
3 Unstoppable Stocks to Keep Buying in 2023
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.